OXBOF (Oxford BioDynamics) Book Value per Share: $0.00 (As of Mar. 2026)


What is Oxford BioDynamics Book Value per Share?

Oxford BioDynamics OXBOF Book Value per Share is $0.00 as of Mar. 2026. The stock has 4 warning signs investors should review.

Oxford BioDynamics's book value per share for the quarter that ended in Mar. 2026 was $0.00.

During the past 12 months, Oxford BioDynamics's average Book Value Per Share Growth Rate was -66.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -66.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -57.00% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -30.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Oxford BioDynamics was 38.30% per year. The lowest was -66.20% per year. And the median was -14.40% per year.

Oxford BioDynamics's current price is $0.0025. Its book value per share for the quarter that ended in Mar. 2026 was $0.00. Hence, today's PB Ratio of Oxford BioDynamics is .

During the past 13 years, the highest P/B Ratio of Oxford BioDynamics was 21.64. The lowest was 0.19. And the median was 5.04.


Oxford BioDynamics  (OTCPK:OXBOF) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Oxford BioDynamics Book Value per Share Related Terms


Oxford BioDynamics Book Value per Share Historical Data

* Premium members only.

The historical data trend for Oxford BioDynamics's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford BioDynamics Book Value per Share Chart

Oxford BioDynamics Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.03 0.04 0.02 0.00

Oxford BioDynamics Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.02 0.00 0.00 0.00

OXBOF vs TMO, DHR, IDXX: Book Value per Share Comparison

For the Diagnostics & Research subindustry, Oxford BioDynamics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford BioDynamics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's PB Ratio falls into.



Oxford BioDynamics Book Value per Share Calculation

Oxford BioDynamics's Book Value Per Share for the fiscal year that ended in Sep. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.51-0.00)/1,957.58
=0.00

Oxford BioDynamics's Book Value Per Share for the quarter that ended in Mar. 2026 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(4.34-0.00)/4,290.91
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of $0.00 mean?
Oxford BioDynamics (OXBOF) has a Book Value per Share of $0.00 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Oxford BioDynamics and its competitors.
Is Oxford BioDynamics' Book Value per Share too high?
Oxford BioDynamics' current Book Value per Share is $0.00.
How does Oxford BioDynamics' Book Value per Share compare to TMO and DHR?
Oxford BioDynamics' Book Value per Share of $0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Diagnostics & Research company?
A good Book Value per Share depends on the Medical Diagnostics & Research industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Oxford BioDynamics and its competitors. Oxford BioDynamics's current Book Value per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioDynamics stock overvalued right now?
Based on GuruFocus' analysis, Oxford BioDynamics (OXBOF) is currently considered Possible Value Trap. The current Book Value per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Oxford BioDynamics (OXBOF), the current Book Value per Share is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oxford BioDynamics Business Description

Other Exchanges OBD:UKLMQ:Germany
Address John Smith Drive, 3140 Rowan Place, Oxford Business Park South, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.